Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) Price and Market Data

Sanofi develops and markets pharmaceuticals with a focus on immunology, vaccines, and rare diseases. While the company maintains a broad portfolio of medicines, its top-selling product, Dupixent, generates more than 30% of total revenue. Profit from this blockbuster immunology therapy is shared with Regeneron. Approximately 45% of Sanofi’s revenue comes from the United States, 20% from Europe, and 6% from China.